Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Shuja Rasool is active.

Publication


Featured researches published by Shuja Rasool.


Journal of the American Heart Association | 2013

Beta and Angiotensin Blockades Are Associated With Improved 10-Year Survival in Renal Transplant Recipients

Waqas Aftab; Padmini Varadarajan; Shuja Rasool; A. Kore; Ramdas G. Pai

Background Mortality in allograft kidney transplant recipients is high, and cardiovascular disease is the leading cause of death in these patients. They have heightened activity of sympathetic and renin–angiotensin systems. We tested the hypothesis that blockade of sympathetic and renin–angiotensin systems in these patients may offer a survival benefit using a large cohort of patients with long‐term follow up. Methods and Results Medical records of 321 consecutive patients from our institution who had received renal transplantation between 1995 and 2003 were abstracted. Survival was analyzed as a function of pharmacological therapies adjusted for age, sex, and comorbidities. The characteristics of the 321 patients were as follows: age at transplant, 44±13 years; 40% male; 89% with hypertension; 36% with diabetes, and mean left ventricular ejection fraction of 60%. Over a follow‐up of 10±4 years, there were 119 deaths. Adjusted for age, sex, diabetes, and coronary artery disease, use of a beta‐blocker therapy (P=0.04) and angiotensin‐converting enzyme inhibitor or receptor blocker (P=0.03) was associated with better survival. This treatment effect was seen across all major clinical subgroups and was supported by propensity score analysis. The propensity score–adjusted 10‐year survival was 95% in those taking both groups of medications, 72% in those taking either of them, and 64% in those taking neither (P=0.004). Conclusions Use of beta‐blocker and angiotensin blocking therapies is associated with higher survival after renal transplantation, indicating their potential protective role in this high‐risk population.


International Journal of Angiology | 2012

Reduced survival in patients with "coronary microvascular disease".

Terence Lin; Stephen Rechenmacher; Shuja Rasool; Padmini Varadarajan; Ramdas G. Pai

The syndrome of chest pain, abnormal stress test, and nonflow limiting coronary artery disease (CAD) is common and is attributed to coronary microvascular disease (µVD). It is associated with increased hospital admissions and health care costs. But its impact on long-term survival is not known. Of the 9941 consecutive patients who had an exercise stress test for evaluation of chest pain between May 1991 and July 2007, 935 had both a positive stress test and a coronary angiogram within 1 year of their stress test forming the study cohort. Significant angiographic CAD defined as ≥70% stenosis of an epicardial coronary artery or ≥50% stenosis of the left main coronary artery was present in 324 patients. Rest (n = 611) were considered to have coronary µVD. Compared with patients with significant epicardial CAD, patients with coronary µVD were younger (63 ± 11 vs. 65 ± 10 years, p = 0.002), and had lower left ventricular wall thickness (p < 0.02), systolic blood pressure (BP; p = 0.002), pulse pressure (0.0008), systolic BP with exercise (p = 0.0001), and pulse pressure with exercise (p < 0.0001). Those with coronary µVD had a better survival compared with those with significant epicardial CAD, but worse than that expected for age- and gender-matched population (p < 0.0001). Coronary µVD as a cause of chest pain and positive stress test is common. All-cause mortality in patients with coronary µVD is worse than in an age- and gender-matched population control, but better than those with significant epicardial CAD.


International Journal of Angiology | 2014

Predictors and Prognostic Implications of Major Adverse Cardiovascular Events after Renal Transplant: 10 Years Outcomes in 321 Patients

Waqas Aftab; Padmini Varadarajan; Shuja Rasool; Ramdas G. Pai

Renal transplantation is the treatment of choice in patients with end-stage renal disease. Major adverse cardiac events (MACE) are common after renal transplant, especially in the perioperative period, leading to excess morbidity and mortality. The predictors and long-term prognostic implications of MACE are poorly understood. We analyzed predictors and implications of MACE in a cohort of 321 consecutive adult patients, who received renal allograft transplantation between 1995 and 2003 at our institution. The characteristics of 321 patients were: age at transplant 44 ± 13 years, 60% male, 36% diabetes mellitus (DM), left ventricular ejection fraction (LVEF) 60 ± 16%. MACE occurred in 21 patients with cumulative rate of 6.5% over 3 years after renal transplant, 57% occurring within 30 days, 67% within 90 days, and 86% within 180 days. MACE was not predicted by any clinical or pharmacological variables including age, gender, hypertension, DM, prior myocardial infarction, smoking, duration of dialysis, LVEF, or therapy with β-blockers (BB), angiotensin converting enzyme inhibitors, or calcium channel blockers. However, a clinical decision to perform a stress test or a coronary angiogram was predictive of higher MACE rate. MACE, irrespective of type, was independently associated with higher mortality over a period up to 15 years and this seemed to be blunted by BB therapy. MACE rate after renal transplantation decreases over time, most occurring in the first 90 days and is not predicted by any of the traditional risk factors or drug therapies. It is associated with higher long-term mortality.


Journal of the American College of Cardiology | 2012

HIGH PREVALENCE AND CLINICAL SIGNIFICANCE OF HYPERTENSIVE RESPONSE TO DOBUTAMINE STRESS IN END STAGE RENAL DISEASE PATIENTS UNDERGOING EVALUATION FOR RENAL TRANSPLANTATION

Waqas Aftab; Shuja Rasool; Padmini Varadarajan; Ali Motabar; Juliana Gazallo; Arputharaj Kore; Michel DeVera; Ramdas G. Pai

Patients with end stage renal disease (ESRD) have a cardiovascular mortality about 15-30 times the general population. Dobutamine stress echocardiography (DSE) is commonly performed in their preoperative cardiac evaluation before renal transplantation. Hypertensive response during DSE defined as


Journal of the American College of Cardiology | 2012

BIOLOGICAL CORRELATES AND CLINICAL IMPLICATION OF ANGIOGRAPHICALLY DETECTED CORONARY ARTERY CALCIFICATION IN PATIENTS WITH END STAGE RENAL DISEASE

Waqas Aftab; Hammad Khan; Patrick Antoun; Padmini Varadarajan; Shuja Rasool; Ali Motabar; Juliana Gazallo; Michel DeVera; Arputharaj Kore; Ramdas G. Pai


Journal of the American College of Cardiology | 2012

VOLUME EXCESS CAUSING HEART FAILURE WITH NORMAL EJECTION FRACTION IS A STRONG PREDICTOR OF MORTALITY IN PATIENTS WITH END STAGE RENAL DISEASE

Waqas Aftab; Padmini Varadarajan; Shuja Rasool; Juliana Gazallo; Ali Motabar; Hatem Ali; Arputharaj Kore; Michel DeVera; Ramdas G. Pai


Circulation | 2012

Abstract 12531: High Left Atrial Volume Impairs Survival in End Stage Renal Disease: Results From a Prospective Cohort of 575 Patients

Ali Motabar; Waqas Aftab; Juliana Gazallo; Shuja Rasool; Padmini Varadarajan; Ramdas G. Pai


Circulation | 2012

Abstract 12517: Statin Therapy in Hemodialysis Patients improves Survival

Waqas Aftab; Juliana Gazallo; Ali Motabar; Shuja Rasool; Padmini Varadarajan; Ramdas G. Pai


Circulation | 2012

Abstract 19383: Reduced Longitudinal and Circumferential Strains with Radial Compensation in End Stage Renal Disease Patients Despite Normal Ejection Fraction

Padmini Varadarajan; Shuja Rasool; Waqas Aftab; Ramdas G. Pai


Circulation | 2011

Abstract 16874: Predictors of Major Adverse Cardiac Events in Renal Transplant Recipients

Waqas Aftab; Shuja Rasool; Padmini Varadarajan; Ramdas G. Pai

Collaboration


Dive into the Shuja Rasool's collaboration.

Top Co-Authors

Avatar

Padmini Varadarajan

University of Southern California

View shared research outputs
Top Co-Authors

Avatar

Ramdas G. Pai

Loma Linda University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Waqas Aftab

Loma Linda University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Ali Motabar

Loma Linda University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Juliana Gazallo

Loma Linda University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Arputharaj Kore

Loma Linda University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Michel DeVera

Loma Linda University Medical Center

View shared research outputs
Top Co-Authors

Avatar

A. Kore

Loma Linda University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hammad Khan

Loma Linda University Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge